-

INVESTOR ALERT: Shareholder Lawsuit Filed Against Pzena Investment Management, Inc. (NYSE: PZN) in Connection with Proposed Sale of the Company

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that a shareholder lawsuit has been filed against Pzena Investment Management, Inc. (NYSE: PZN) (“Pzena”), and certain of the company’s executive officers and directors, in connection with the proposed sale of Pzena at $9.60 per share.

According to the complaint, the defendants violated the securities laws by filing a materially incomplete and misleading proxy statement, which omits or misrepresents material information necessary and essential to investors’ decision on whether to approve the proposed transaction at $9.60 per share.

Pzena shareholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/pzena-investment-management/ , for additional information about this action and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

This notice may constitute attorney advertising in certain jurisdictions.

Contacts

D. Seamus Kaskela, Esq.
skaskela@kaskelalaw.com
Adrienne Bell, Esq.
abell@kaskelalaw.com
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Industry:

Kaskela Law LLC

NYSE:PZN
Release Versions
English

Contacts

D. Seamus Kaskela, Esq.
skaskela@kaskelalaw.com
Adrienne Bell, Esq.
abell@kaskelalaw.com
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

SELECT MEDICAL STOCK ALERT: Does $16.50 Per Share Represent a Fair Shareholder Buyout Price? Kaskela Law Firm Announces Investigation into Fairness of Buyout Offer and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC is investigating the recently announced buyout of Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholders to determine whether the $16.50 per share buyout offer is fair to the company’s investors or if it undervalues the company’s shares. Click here for additional information: https://kaskelalaw.com/case/select-medical/ On March 2, 2026, Select Medical announced that it had agreed to be acquired by an investment consortium at a pr...

CWAN STOCKHOLDER NOTE: Kaskela Law Firm Announces Investigation into Clearwater Analytics Holdings, Inc. Stockholder Buyout and Encourages Investors to Contact the Firm – CWAN

PHILADELPHIA--(BUSINESS WIRE)--On behalf of Clearwater Analytics Holdings, Inc. (NYSE: CWAN) (“Clearwater”) stockholders, Kaskela Law LLC announces that it is actively investigating the recently announced proposed buyout of Clearwater’s investors to determine whether the buyout price provides investors with sufficient monetary consideration for their shares. Click here to request additional information: https://kaskelalaw.com/case/clearwater-analytics-buyout/ On December 21, 2025, Clearwater an...

ONESTREAM SHAREHOLDER NOTE: Kaskela Law Firm Announces Investigation of OneStream, Inc. Shareholder Buyout Proposal and Encourages Investors to Contact the Firm – OS

PHILADELPHIA--(BUSINESS WIRE)--On behalf of OneStream, Inc. (NASDAQ: OS) investors, Kaskela Law LLC announces that it is investigating the recently announced proposed buyout of OneStream’s shareholders to determine whether the buyout price provides investors with a high enough buyout price for their OneStream shares. Click here to request additional information: https://kaskelalaw.com/case/onestream/ On January 6, 2026, OneStream announced that it had agreed to be acquired by private equity fir...
Back to Newsroom